Indivior Revenue, Growth & Competitor Profile

DBA INDIVIOR PLC
DBA RECKITT BENCKISER PHARMACEUTICALS INC.

Company Profile & Annual Report for Indivior

Access the complete profile.

Indivior Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	10710 Midlothian Turnpike Suite 125 North Chesterfield, VA 23235

Note: Revenues for privately held companies are statistical evaluations.


Indivior's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Indivior's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Indivior is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Indivior Annual Revenue and Growth Rate

Indivior	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Indivior's revenues are gauged from an analysis of company filings.

Indivior's Income Statement (based on Industry Averages)

Indivior P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Indivior is developing and marketing. Indivior's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ZIPVA Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparation, namely, an opioid antagonist	04/19/2023
ZAPYD Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparation, namely, an opioid antagonist	04/19/2023
OPVEE Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparation, namely, an opioid antagonist	09/23/2021

See all trademarks and details in the Full Report.

Market Share of Indivior's Largest Competitors

A competitive analysis shows these companies are in the same general field as Indivior, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Indivior. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
INDIVIOR	North Chesterfield, VA	100
FAREVA RICHMOND	Richmond, VA	94
PHLOW	Richmond, VA	8
TCG GREENCHEM	Richmond, VA	1

Future Competition: Indivior's Fastest Growing Competitors

These companies are in the same general field as Indivior and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)